atezolizumab plus bevacizumab plus carboplatin plus paclitaxel
atezolizumab plus carboplatin plus nab-paclitaxel
atezolizumab plus carboplatin plus paclitaxel
non squamous - mNSCLC - L1 - all population 3
Comparator:
vs bevacizumab plus carboplatin and paclitaxel; vs atezolizumab plus carboplatin plus nab-paclitaxel;
Risk of bias:
low;
some concerns;
high;
NA;